NEW ZEALAND GAZETTE, No. 88

22 JULY 2010

Medicines for General Sale

Please note that the following medicine is now available for general sale:

Loperamide; in divided solid dosage forms for oral use containing 2 milligrams or less of loperamide per dosage form when sold in a pack containing not more than eight dosage forms approved by the Minister or the Director-General for distribution as a general sale medicine for the symptomatic treatment of acute non-specific diarrhoea.

Dated this 13th day of July 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health.

go5551

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Janice Wilson, Deputy Director-General, Population Health Directorate, Ministry of Health, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

Chloramphenicol; except when sold in practice by a registered optometrist; except when specified elsewhere in this notice

Corifollitropin alfa

Famciclovir; except when specified elsewhere in this notice

Fexofenadine; except for oral use

Heparins; for internal use; except when present as an excipient

Human papillomavirus vaccine

Ibogaine

Japanese encephalitis vaccine

Lansoprazole; except when specified elsewhere in this notice

Noribogaine

Omeprazole; except when specified elsewhere in this notice

Pazopanib

Phosphodiesterase type 5 inhibitors; except when present as an unmodified, naturally occurring substance; except when specified elsewhere in this notice

Stramonium; except for oral use when specified elsewhere in this notice; except datura stramonium or datura tatula for smoking or burning

Zolmitriptan; except when specified elsewhere in this notice

Schedule 2

Restricted Medicines

Chloramphenicol; for ophthalmic use; except when sold in practice by a registered optometrist

Famciclovir; in tablets containing 500 milligrams or less when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine

Lansoprazole; in tablets or capsules containing 15 milligrams or less when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine

Omeprazole; in tablets or capsules containing 20 milligrams or less when sold in a pack approved by the Minister or the Director-General for distribution as a restricted medicine

Zolmitriptan; in a prefilled nasal spray device containing not more than 5 milligrams, for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms, when sold in a pack of not more than two devices approved by the Minister or the Director-General for distribution as a restricted medicine

Schedule 3

Pharmacy-only Medicines

Fexofenadine; for oral use; except when in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride when sold in a pack approved by the Minister or the Director-General for distribution as a general sale medicine

Stramonium; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

Medicines for General Sale

Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale.

Fexofenadine; in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride when sold in a pack approved by the Minister or the Director-General for distribution as a general sale medicine

Heparins; for external use; when present as an excipient

Dated this 13th day of July 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health.

go5558